Subscribe to our Newsletter

Salarius Pharmaceuticals is an innovative biotechnology Company whose mission is to capitalize on the emerging understanding of the role of epigenetics in cancer. The Company has developed a potent compound that inhibits the expression of genes that promote cancer states in various cancers. Salarius Pharmaceuticals believes this compound will show remarkable clinical response and is therefore in the process of bringing this molecule to a Phase I clinical trial. Due to the Company’s initial success in developing this lead compound – SP2577 – and ability to resource the Company’s entry into clinical trials, Salarius has the need for an Office Manager.